1. Home
  2. MMU vs ACHV Comparison

MMU vs ACHV Comparison

Compare MMU & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Managed Municipals Fund Inc.

MMU

Western Asset Managed Municipals Fund Inc.

HOLD

Current Price

$10.45

Market Cap

561.5M

Sector

Finance

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$6.48

Market Cap

618.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMU
ACHV
Founded
1992
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.5M
618.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MMU
ACHV
Price
$10.45
$6.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.67
AVG Volume (30 Days)
120.4K
2.7M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
4.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.79
$2.38
52 Week High
$10.71
$7.11

Technical Indicators

Market Signals
Indicator
MMU
ACHV
Relative Strength Index (RSI) 60.11 66.69
Support Level $10.27 $4.09
Resistance Level $10.49 N/A
Average True Range (ATR) 0.10 0.47
MACD 0.01 0.10
Stochastic Oscillator 58.33 71.83

Price Performance

Historical Comparison
MMU
ACHV

About MMU Western Asset Managed Municipals Fund Inc.

Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. The fund predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations).

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: